BIOTRONIK is releasing a new implantable cardiac monitor that’s indicated for long term analysis of patients’ cardiac patterns. Though it looks like a typical pacemaker, the device does not have leads going to the heart.
It’s essentially a continuous three channel ECG system that also includes BIOTRONIK’s home monitoring technology. The complete system automatically and continuously monitors the heart and regularly sends data from the implant to the patient’s cardiologist for review. Batteries within the implant are rated for 6.4 years of continuous use, which should help physicians identify long term patterns in difficult to diagnose patients.
As sensitivity and specificity are essential in the detection of arrhythmias such as AF, BIOTRONIK has developed ClearSense Technology with a unique three-vector signal detection that produces highly precise and reliable arrhythmia monitoring.
The ClearSense Technology records three ECG channels converting them to one high quality ECG input signal to clearly distinguish on a beat-to-beat basis between a genuine signal and other artifacts such as myopotentials due to body muscle contractions. This innovative technology allows for optimal arrhythmia detection independent of the device’s implant orientation within the body and provides a longevity of 6.4 years.
BioMonitor® is equipped with BIOTRONIK’s home monitoring system, which provides daily remote data transfer without patient interaction—leading to high patient compliance. Its traffic light system streamlines monitoring by highlighting the most relevant information and providing accurate data for physicians to monitor and manage their patients effectively.
Press release: BIOTRONIK Launches Implantable BioMonitor® – Highest Precision in Monitoring Arrhythmias